CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −34,972 | $60.19 | $2.1M | 6,767 |
| 2026-01-22 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −60,000 | $60.23 | $3.6M | 134,201 |
| 2026-01-20 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −21,433 | $51.61 | $1.1M | 202,768 |
| 2026-01-20 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −8,567 | $52.10 | $446K | 194,201 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −18,933 | $60.18 | $1.1M | 17,534 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −5,004 | $60.00 | $300K | 12,530 |
| 2026-01-06 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −5,763 | $60.21 | $347K | 6,767 |
| 2025-12-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −3,528 | $55.10 | $194K | 13,239 |
| 2025-12-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −5,472 | $56.33 | $308K | 7,767 |
| 2025-12-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −1,000 | $56.89 | $57K | 6,767 |
| 2025-10-17 | Kulkarni Samarth Chief Executive Officer | Sale | −50,895 | $67.91 | $3.5M | 254,201 |
| 2025-10-14 | Kulkarni Samarth Chief Executive Officer | Sale | −4,242 | $66.60 | $283K | 205,096 |
| 2025-10-14 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,076 | $66.60 | $72K | 83,402 |
| 2025-08-18 | Kulkarni Samarth Chief Executive Officer | Sale | −13,081 | $58.15 | $761K | 207,004 |
| 2025-05-29 | Patel Naimish Chief Medical Officer | Sale | −3,932 | $35.94 | $141K | 6,068 |
| 2025-03-21 | Kulkarni Samarth Chief Executive Officer | Sale | −10,031 | $41.23 | $414K | 195,085 |
| 2025-03-21 | Bruno Julianne Chief Operating Officer | Sale | −1,714 | $41.23 | $71K | 10,544 |
| 2025-03-21 | Prasad Raju Chief Financial Officer | Sale | −2,197 | $41.23 | $91K | 16,767 |
| 2025-03-21 | KASINGER JAMES R. General Counsel and Secretary | Sale | −3,185 | $41.23 | $131K | 81,729 |
| 2025-03-17 | Prasad Raju Chief Financial Officer | Sale | −3,762 | $41.80 | $157K | 12,714 |
Page 2 of 27 · 528 trades